ExploreWatchlistsPricing
  1. JP-listed companies
  2. Fuso Pharmaceutical Industries,Ltd.
  3. Financials
  4. Cash from operations

Fuso Pharmaceutical Industries,Ltd. (4538)

Market cap
¥21.8B
P/E ratio
8.6x
Fuso Pharmaceutical Industries manufactures injectable medicines like intravenous solutions and kidney dialysis products, while also operating real estate leasing.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCash from operations (Million JPY)YoY (%)
Mar 31, 2025-3,305-627.11%
Mar 31, 2024627-78.02%
Mar 31, 20232,853-18.44%
Mar 31, 20223,498+8.30%
Mar 31, 20213,230-43.59%
Mar 31, 20205,726+179.18%
Mar 31, 20192,051+44.44%
Mar 31, 20181,420-24.31%
Mar 31, 20171,876-11.38%
Mar 31, 20162,117+8.96%
Mar 31, 20151,943

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat